| Current Price | $42.45 | Mkt Cap | $2.70B |
|---|---|---|---|
| Open | $0.00 | P/E Ratio | 0.00 |
| Prev. Close | $42.54 | Div. (Yield) | N/A (N/A) |
| Daily Range | $41.66 - $42.68 | Volume | 635,784 |
| 52-Wk Range | $27.17 - $46.07 | Avg. Daily Vol. | 0 |
News & Discussion Boards
- Onyx Pharmaceuticals Announces Fourth Quarter and Full Year 2011 Financial Results Teleconference and Webcast 2/9/2012 4:00:00 PM -
- Pfizer Wins U.S. FDA Approval for Advanced Kidney-Cancer Treatment Inlyta 1/27/2012 4:19:43 PM -
- Is M&A The New R&D? 1/26/2012 4:45:35 PM -
- FDA OKs Millennium's Velcade Injection 1/23/2012 4:25:29 PM -
- Kidney Cancer? There's a Drug for That 1/31/2012 6:00:48 PM
- Kidney Cancer? There's a Drug for That 1/31/2012 5:58:46 PM
- 3 Biotech Buyout Candidates for 2012 1/30/2012 7:33:16 PM
- 3 Biotech Buyout Candidates for 2012 1/30/2012 7:33:16 PM
| Subject | Recs | Author | Date |
|---|



